Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.00%
)
US TECH 100
29,575.60
(
0.15%
)
Dow Jones
51,032.46
(
0.00%
)
Brent Oil
94.25
(
3.16%
)
Bitcoin
71,866.01
(
-2.30%
)
News Focus
News Focus
Post# of 57994
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 98
Posts 39017
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: icebrg post# 4513

Monday, 03/12/2007 5:49:07 AM

Monday, March 12, 2007 5:49:07 AM

Post# of 57994
Hi Erik, Asenapine is apparently a dog, and Pfizer bailed on it. Organon has $5 bil in other ongoing revenues though, so I guess a $14 bil price tag for the company isn't too unreasonable even if Asenapine flops. I wonder if Schering will try to get out of the NIMH/TURNS committment?






Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today